RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Xinbin Gu to Drug Resistance, Neoplasm

Back to Details
This is a "connection" page, showing publications Xinbin Gu has written about Drug Resistance, Neoplasm.
Xinbin Gu
Connection Strength
0.066
Drug Resistance, Neoplasm
  1. Yang C, Pang X, Teng S, Wilson S, Gu X, Xie G. MYC Overexpression Enhances Sensitivity to MEK Inhibition in Head and Neck Squamous Cell Carcinoma. Int J Mol Sci. 2025 Jan 12; 26(2).
    View in: PubMed
    Score: 0.047
  2. Zhou Y, Sridhar R, Shan L, Sha W, Gu X, Sukumar S. Loperamide, an FDA-approved antidiarrhea drug, effectively reverses the resistance of multidrug resistant MCF-7/MDR1 human breast cancer cells to doxorubicin-induced cytotoxicity. Cancer Invest. 2012 Feb; 30(2):119-25.
    View in: PubMed
    Score: 0.019
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support